Skip to content

Comparison of drug-eluting and plain balloon angioplasty in the treatment of stenosis of vascular access for dialysis

Comparison of drug-eluting and plain balloon angioplasty in the treatment of stenosis of vascular access for dialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11414306
Enrollment
70
Registered
2022-12-01
Start date
2018-10-19
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment with stenosis in the vascular access for dialysis in adult patients using percutaneous transluminal angioplasty Surgery

Interventions

The aim of this study was to evaluate if adult patients with stenosis in dialysis vascular access would benefit from the use of a drug-eluting balloon. The patients are referred from d

Sponsors

Charles University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >18 years old 2. Life expectancy >1 year 3. Clinically mature dialysis fistula (AVG or AVF) already used for hemodialysis with adequate pump speed and dialysis efficacy for at least 4 consecutive sessions with the two-needle technique 4. Signs of fistula dysfunction (absent thrill, low flow, high venous pressure, high pulsatility, needling problems, abnormal pulsatility, abnormal auscultation, extremity edema, etc) 5. Hemodynamically significant (>50%) stenosis in juxta-anastomotic or outflow vein of AVF (excluding central veins defined as veins medial to the lateral margin of the first rib) or in the venous anastomosis, juxta-anastomotic segment or outflow vein in AVG (excluding central veins).

Exclusion criteria

Exclusion criteria: 1. Access circuit thrombosis in the last year 2. History of graft infection 3. Prior use of a drug-eluting balloon catheter in the access circuit 4. In-stent restenosis in bare metal or covered stent 5. Angiography contraindications (e.g. severe contrast media allergy) 6. Two or more distinct significant stenoses in the access circuit

Design outcomes

Primary

MeasureTime frame
Primary patency rates measured using angiography and the need for repeated intervention at 3, 6, 9, 12 months or earlier if requested by the physician

Secondary

MeasureTime frame
Median time to target lesion re-intervention measured using medical records and angiography at 3, 6, 9, 12 months or earlier if requested by the physician

Countries

Czech Republic

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 10, 2026